UK's Ranier gets £8m for spinal implants:
This article was originally published in Clinica
Executive Summary
Ranier Technology has secured £8m ($16m) in new capital to fund the development and commercialisation of its motion-preserving spinal implants. Participating in the financing round were new investor Alliance Trust Equity Partners and existing shareholder First Ventures. Cambridge, UK-based Ranier will use the proceeds for the clinical trials and European launch of CAdisc L, a replacement spinal disc for the lumbar region, as well as for the development of CAdisc C, a cervical version of the product.